Excerpt
To the Editor:
Osteoporosis is becoming a serious public health problem in Asian countries. Hip fractures represent the most significant osteoporotic fractures. Except under conditions of extremely poor health status, treatment with surgical intervention and early mobilization remains the gold standard for treating hip fractures. Recently, teriparatide, recombinant parathyroid hormone (PTH 1-34), has been approved for treatment of osteoporosis. We describe an enhanced callus formation phenomenon in a patient with hip fracture who was treated by internal fixation and daily PTH 1-34 injection.
A 62-year-old woman with liver cirrhosis experienced sudden right groin pain when undertaking rehabilitation. Radiographs revealed a…